A novel 99m Tc‐diester complex as tumor targeting agent: Synthesis, radiolabeling, and biological distribution study
Journal of Labelled Compounds and Radiopharmaceuticals · 30.06.2020 · 63 (8) · 376-385
DOI: 10.1002/jlcr.3841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 19.05.2020. Verfasst von Hesham A Shamsel-Din und 3 weiteren Autor:innen. Beteiligte Einrichtung: Radioisotopes Production Facility (RPF), Second Research Reactor (ETRR-2), Atomic Energy Authority, Cairo, Egypt. Hauptthemen laut MEDLINE: Isotope Labeling, Radiopharmaceuticals. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
The target of this study is the synthesis of a new diester derivative and radiolabeling with one of the most effective diagnostic radioisotopes to be investigated as a novel targeting radiotracer for tumor imaging. 10‐[2‐(9‐Carboxynonanoyloxy)propoxy]‐10‐oxodecanoic acid was synthesized in excellent yield and characterized by Fourier‐transform infrared spectroscopy, mass, 1 H‐NMR, and 13 C‐NMR spectra. The diester was technetium‐99m ( 99m Tc) radiolabeled by direct technique using sodium dithionite as a reducing agent. The labeling parameters such as diester amount, reducing agent amount, pH of the medium, and reaction time were optimized. High radiochemical yield of 95.10 ± 0.41% and in vitro stability in serum up to 12 h have been obtained on complexation of the synthesized diester with Tc‐99m. Evaluation of the diester anticancer activity against breast cancer cell line (MCF‐7) showed high percent of inhibition about 61.5% at 100 μg/ml. The rhenium complex of the diester was synthesized and characterized by liquid chromatography–mass spectrometry (ESI) and elemental analysis depending on the strong chemical resemblance between Tc and Re. Biodistribution studies of 99m Tc‐diester complex showed high target to nontarget ratio (T/NT) equals 6.24 ± 0.09 in tumor‐bearing mice at 30‐min postinjection, suggesting this complex could be used as hopeful solid tumor‐imaging agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radioisotopes Production Facility (RPF), Second Research Reactor (ETRR-2), Atomic Energy Authority, Cairo, Egypt.
- Labeled Compounds Department, Hot Labs Center, Atomic Energy Authority, Cairo, Egypt.
- Petroleum Applications Department, Egyptian Petroleum Research Institute, Cairo, Egypt.
ORCID-Profile: Mohamed A Gizawy
Zitieren
APA
Shamsel-Din, H. A., Gizawy, M. A., Zaki, E. G., & Elgendy, A. (2020). A novel 99m Tc‐diester complex as tumor targeting agent: Synthesis, radiolabeling, and biological distribution study. Journal of Labelled Compounds and Radiopharmaceuticals, 63(8), 376-385. https://doi.org/10.1002/jlcr.3841
Vancouver
Shamsel-Din HA, Gizawy MA, Zaki EG, Elgendy A. A novel 99m Tc‐diester complex as tumor targeting agent: Synthesis, radiolabeling, and biological distribution study. Journal of Labelled Compounds and Radiopharmaceuticals. 2020;63(8):376-385. doi:10.1002/jlcr.3841
BibTeX
@article{ShamselDin2020,
author = {Shamsel-Din, Hesham A and Gizawy, Mohamed A and Zaki, Elsayed G and Elgendy, Amr},
title = {A novel 99m Tc‐diester complex as tumor targeting agent: Synthesis, radiolabeling, and biological distribution study},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2020},
volume = {63},
number = {8},
pages = {376--385},
doi = {10.1002/jlcr.3841}
}
EUVIMED